Posted by Michael Wonder on 19 Apr 2022
Prescription medicines: applications under evaluation (April 2022)
19 April 2022 - The TGA has updated its list of applications for new medicines or new uses for existing medicines that are currently under evaluation.
Eight new applications were accepted by the TGA for evaluation in March:
- Belzutifan - new medicine
- Remdesivir - new indication
- Pneumococcal conjugate vaccine (15 valent) - new indication
- Nivolumab - new indication
- Finerenone - new indication
- Damoctocog alfa pegol - new blood product
- Clobetasol propionate - new indication
- Buprenorphine - new indication
